Camós-Carreras Anna, Alba-Arbalat Salut, Dotti-Boada Marina, Parrado-Carrillo Alba, Bernal-Morales Carolina, Saiz Albert, Sánchez-Dalmau Bernardo
Ophthalmology Department, Hospital Clinic de Barcelona, Barcelona, Spain.
Neurology Department, Hospital Clinic de Barcelona, Barcelona, Spain.
Neuroophthalmology. 2020 Oct 6;45(1):61-64. doi: 10.1080/01658107.2020.1821065. eCollection 2021.
Macular oedema is a rare complication of fingolimod treatment. It usually presents within 3-4 months, but occasionally presents later. It can resolve without treatment despite continuation of fingolimod treatment. Herein we report a case of very late onset macular oedema in a 49-year-old woman with multiple sclerosis treated with fingolimod for 7 years. The patient presented with blurred vision in both eyes with visual acuities of 20/32 in her right eye and 20/25 in her left eye. She had macular oedema, that without discontinuing fingolimod treatment, resolved after 1 month.
黄斑水肿是芬戈莫德治疗的一种罕见并发症。它通常在3 - 4个月内出现，但偶尔也会在更晚的时候出现。尽管继续使用芬戈莫德治疗，它仍可在未经治疗的情况下自行消退。在此，我们报告一例49岁患有多发性硬化症的女性，使用芬戈莫德治疗7年后出现非常迟发性黄斑水肿的病例。该患者双眼视力模糊，右眼视力为20/32，左眼视力为20/25。她患有黄斑水肿，在未停用芬戈莫德治疗的情况下，1个月后水肿消退。
